©The Author(s) 2025.
World J Gastrointest Oncol. Sep 15, 2025; 17(9): 109949
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.109949
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.109949
Figure 1 Kaplan-Meier curve of original cohort.
A: Kaplan-Meier curve of original cohort (progression-free survival); B: Kaplan-Meier curve of original cohort (overall survival). SOC: Standard-of-care; CIT: Chemoimmunotherapy.
- Citation: Gao Z, Zhou ZF, Wang XY, Song T, Wu SK, Jin X. Chemotherapy plus bevacizumab vs chemoimmunotherapy for metastatic colorectal cancer: Real-world analysis. World J Gastrointest Oncol 2025; 17(9): 109949
- URL: https://www.wjgnet.com/1948-5204/full/v17/i9/109949.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i9.109949